Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Case series:N/A
Sponsors
Tongji hospital, Tongji medical College, Huazhong University of Science and Technology
Eligibility
Sex/Gender
All
Age
10 Years to 88 Years
Inclusion criteria
Inclusion criteria: (1) Subjects must understand the clinical trial requirements and potential risks, with voluntarily participation, and sign the informed consent; (2) Fever and/or respiratory symptoms, normal or reduced total white blood cell count in the early stage of disease, or reduced lymphocyte count; (3) With an epidemiological history and radiological features of viral pneumonia; (4) Respiratory tract specimens were detected positive for sars-cov-2 virus nucleic acid by RT-PCR
Exclusion criteria
Exclusion criteria: (1) Infection with influenza virus, parainfluenza virus, adenovirus, respiratory syncytial virus, rhinovirus, human partial pneumonovirus, SARS coronavirus and other known viral pneumonia patients; (2) Patients with mycoplasma pneumoniae, chlamydia pneumonia and bacterial pneumonia; (3) Patients with non-infectious diseases, such as vasculitis, dermatomyositis and mechanical pneumonia; (4) Clinical diagnosis of SARS- Cov-2 virus nucleic acid test negative in respiratory tract swab.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ocular Symptoms; | — |
Countries
China
Contacts
Public ContactJunming Wang
Tongji hospital, Tongji medical College, Huazhong University of Science and Technology
Outcome results
None listed